Cycle Pharmaceuticals reflects on 65 years of progress in Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) during Leukemia Awareness Month.

We’re committed to supporting patients and their caregivers in every way we can. They are at the heart of everything we do. We focus on providing treatments and services for patients with neurological, rare metabolic, and rare immunological conditions, most of which are genetic conditions. We also provide a treatment for patients with rare types of leukaemia. We’re headquartered in Cambridge, UK and have staff working across the US, with an office in Detroit, MI.